RECRUITING

The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Low glycemic index nutritional shakes have clinically shown to improve post-prandial glycemic responses in acute laboratory control studies. However, there is limited information on how replacing meals with low-glycemic index shake could impact glucose regulation in free-living adults consuming their own diets. The present study aims to examine the impact of adding the SP Glucose-Assist shake to the breakfast of non-diabetic overweight and obese adults. Subjects: 40 non-diabetic adults aged 25-65 years and body mass index ranging between 25-39 . Protocol: This is going to be a three-week study that will include a one-week self-selected diet, followed by two weeks of a breakfast supplement shake (standard process glucose assist) or control cereal oat breakfast.

Official Title

The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults

Quick Facts

Study Start:2025-03-14
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06856460

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Body mass index 25-40
  2. * Eating pattern 3 meals a day
  3. * stable weight for the last 2 months (\<5 pounds fluctuation)
  4. * Willing to eat oat cereal for breakfast
  5. * glycated hemoglobin \<7%
  1. * glycated hemoglobin \>7%
  2. * Body mass index ≤25 or ≥ 40
  3. * Night shifting work
  4. * Atypical meal pattern (not three meals a day or intermittent fasting)
  5. * Thyroid medication
  6. * Bariatric surgery
  7. * Habitual strenuous exercise
  8. * Commuting by bicycle
  9. * Eating disorders
  10. * Use of aspirin during the duration of the study
  11. * Intake of Vit C \>60 mg/day during the study
  12. * cancer
  13. * cardiovascular disease
  14. * renal disease
  15. * hepatic disease
  16. * X-ray, MRI or CT appointment during the study duration
  17. * Current infection requiring medication
  18. * Chronic, contagious, infectious diseases such as tuberculosis, Hepatitis A, B, C, or HIV
  19. * Medications of supplements that could affect body weight or appetite (i.e. Ozempic)
  20. * Participating in another study at the same time

Contacts and Locations

Study Contact

Alicia Nguyen
CONTACT
480-447-4811
shake.hydration@gmail.com

Study Locations (Sites)

Arizona State University 850 PBC
Phoenix, Arizona, 85004
United States

Collaborators and Investigators

Sponsor: Arizona State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-14
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2025-03-14
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • meal replacement
  • glucose regulation

Additional Relevant MeSH Terms

  • Hyperglycemia
  • Obesity Prevention